Status:
COMPLETED
Chloride Transfer During Continuous Renal Replacement Therapy in the Intensive Care Unit: a Prospective Observational Cohort Study
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
Acute kidney injury (AKI) is a frequently encountered complication in the intensive care unit (ICU), affecting on average 25 to 35% of patients. It is associated with an increased mortality, proportio...
Eligibility Criteria
Inclusion
- Adult patients (age \> 18 years) affiliated to a social security regimen.
- Presenting with stage III AKI according to Kidney Disease: Improving Global Outcome (KDIGO) classification28.
- Treated with continuous RRT (CVVH or CVVD or CVVHDF) for less than 24 hours, whatever the method used.
- Mechanically ventilated at the time of inclusion in the study.
Exclusion
- Patients on chronic hemodialysis / peritoneal dialysis.
- Patients on extracorporeal membrane oxygenation
- Patients on intermittent hemodialysis (acute or chronic)
- RRT initiated for a different reason than stage III AKI according to Kidney Disease: Improving Global Outcome (KDIGO) classification
- Withholding of life sustaining treatment concerning RRT, mechanical ventilation or cardiopulmonary resuscitation.
- Patients whose life expectancy is lower than 24 hours
- Patients under guardianship or another juridical protection
- Patient's or next of kin opposition to participate
- Patients previously included in the study
Key Trial Info
Start Date :
March 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 24 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04755491
Start Date
March 16 2021
End Date
August 24 2022
Last Update
September 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de la Croix-Rousse (Hospices Civils de Lyon) / Médecine Intensive - Réanimation
Lyon, France, 69004